Nextel Medical Cash & Equivalents Growth & History (MAJI)

Nextel Medical's cash and equivalents was $0 for fiscal 2020.

View full Nextel Medical company overview

Nextel Medical annual cash and equivalents history

Nextel Medical annual cash and equivalents

Fiscal yearPeriod endedCash and equivalentsChangeGrowth
20202020-04-30$0$0
20192019-04-30$0−$1,589
20182018-04-30$1,589
20122012-04-30$5,865−$65,295−91.76%
20112011-04-30$71,160$66,242+1346.93%
20102010-04-30$4,918

Nextel Medical cash and equivalents trends

Between the periods ended 2010-04-30 and 2020-04-30, Nextel Medical's cash and equivalents decreased from $4,918 to $0, a change of −$4,918. The latest reported quarter, Q1 2021, shows $0.

About the metric

What cash and equivalents mean

Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.

Calculation and source

Reported cash and equivalents

TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nextel Medical source filings ↗

Community posts

It’s quiet here.

No posts about MAJI yet. Start the conversation.

Write the first post